Literature DB >> 20304097

Low rates of cancer or high-grade dysplasia in colorectal polyps collected from computed tomography colonography screening.

Perry J Pickhardt1, Kendra S Hain, David H Kim, Cesare Hassan.   

Abstract

BACKGROUND & AIMS: In patients with polyps detected at computed tomography colonography (CTC) screening, management decisions are influenced by the likelihood of important polyp histology. We assess the rates of cancer and high-grade dysplasia among patients found to have small (6-9 mm) and large (>or=10 mm) colorectal polyps at CTC.
METHODS: We reviewed results from 5124 consecutive adults (mean age, 56.9 y; 2792 women) who received CTC screening at 1 institution over a 52-month period. All nondiminutive lesions confirmed at subsequent colonoscopy were grouped by size and histology features. Rates of cancer and high-grade dysplasia were calculated for various sizes. Adenomas were classified as advanced if they were 10 mm or greater and/or contained high-grade dysplasia or a prominent villous component.
RESULTS: A total of 755 polyps 6 mm or greater were identified during colonoscopy examinations in 479 patients. The rate of malignancy, according to polyp size, was 0% (0 of 464) for polyps 6 to 9 mm, 0.9% (2 of 216) for polyps 10 to 19 mm, 6.1% (2 of 33) for polyps 20 to 29 mm, and 38.1% (16 of 42) for polyps 30 mm or greater. High-grade dysplasia was observed in 0.4% (2 of 464) of 6- to 9-mm polyps and 7.9% (23 of 291) of lesions 10 mm or greater. A prominent villous component was seen in 3.4% (16 of 464) of 6- to 9-mm polyps. The overall rate of advanced histology in small polyps was 3.9% (18 of 464).
CONCLUSIONS: Small (6-9 mm) polyps rarely contained high-grade dysplasia (0.4%); none was malignant. The malignancy rate for large (1-2 cm) colorectal polyps was less than 1%. These findings indicate the potential for less aggressive management of lesions detected by CTC. Copyright (c) 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20304097     DOI: 10.1016/j.cgh.2010.03.007

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  20 in total

Review 1.  Role of CT colonography in symptomatic assessment, surveillance and screening.

Authors:  L Maximilian Almond; Douglas M Bowley; Sharad S Karandikar; Shuvro H Roy-Choudhury
Journal:  Int J Colorectal Dis       Date:  2011-03-19       Impact factor: 2.571

2.  Volumetric growth rates of sessile serrated adenomas/polyps observed in situ at longitudinal CT colonography.

Authors:  P J Pickhardt; B D Pooler; K A Matkowskyj; D H Kim; W M Grady; R B Halberg
Journal:  Eur Radiol       Date:  2019-02-11       Impact factor: 5.315

Review 3.  The Natural History of Colorectal Polyps: Overview of Predictive Static and Dynamic Features.

Authors:  Perry J Pickhardt; Bryan Dustin Pooler; David H Kim; Cesare Hassan; Kristina A Matkowskyj; Richard B Halberg
Journal:  Gastroenterol Clin North Am       Date:  2018-06-29       Impact factor: 3.806

Review 4.  New insights into the earliest stages of colorectal tumorigenesis.

Authors:  Chelsie K Sievers; William M Grady; Richard B Halberg; Perry J Pickhardt
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2017-05-26       Impact factor: 3.869

Review 5.  Management of subcentimetric polyps detected by CT colonography.

Authors:  Cesare Hassan; Perry J Pickhardt
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-11-20       Impact factor: 46.802

Review 6.  Multi-Target Stool DNA Test: Is the Future Here?

Authors:  Seth Sweetser; David A Ahlquist
Journal:  Curr Gastroenterol Rep       Date:  2016-06

Review 7.  CT colonography: over two decades from discovery to practice.

Authors:  Perry J Pickhardt; Judy Yee; C Daniel Johnson
Journal:  Abdom Radiol (NY)       Date:  2018-03

Review 8.  Colorectal cancer: CT colonography and colonoscopy for detection--systematic review and meta-analysis.

Authors:  Perry J Pickhardt; Cesare Hassan; Steve Halligan; Riccardo Marmo
Journal:  Radiology       Date:  2011-03-17       Impact factor: 11.105

Review 9.  Multi-target stool DNA test: a new high bar for noninvasive screening.

Authors:  David A Ahlquist
Journal:  Dig Dis Sci       Date:  2014-12-10       Impact factor: 3.199

Review 10.  Computed tomography colonography: emerging evidence to further support clinical effectiveness.

Authors:  Perry J Pickhardt
Journal:  Curr Opin Gastroenterol       Date:  2013-01       Impact factor: 3.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.